Warfarin
وارفارین
🩸 Blood And Blood Forming OrgansVitamin K antagonist
Market / country: 🇺🇸 USA
Coumadin (US) · Jantoven (US)
🧮 Dose calculator
Atrial fibrillation / anticoagulation · Regimen source: FDA Warfarin · 2.3FDA Warfarin · 2
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy (except high-risk mechanical valves); haemorrhagic tendencies or blood dyscrasias; recent or planned CNS or eye surgery (and other items in section 4). FDA Warfarin · 4
Formulations
- 1 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 2 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 2.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 3 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 4 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 5 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 6 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 7.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
- 10 mg tablet (scored) — tablet 🇺🇸 USA FDA Warfarin · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Warfarin · 4
“Warfarin sodium tablets, USP are contraindicated in: • Pregnancy Warfarin sodium tablets, USP are contraindicated in women who are pregnant except in pregnant women with mechanical heart valves, who are at high risk of thromboembolism [see Warnings and Precautions (5.7) and Use in Specific Populations (8.1) ].”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Warfarin · 8.2
“Risk Summary Warfarin was not present in human milk from mothers treated with warfarin from a limited published study.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Warfarin · 8.4
“Adequate and well-controlled studies with warfarin sodium have not been conducted in any pediatric population, and the optimum dosing, safety, and efficacy in pediatric patients is unknown.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Warfarin · 8.5
“Conduct more frequent monitoring for bleeding with administration of warfarin sodium to elderly patients in any situation or with any physical condition where added risk of hemorrhage is present.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Warfarin · 8.3
“Contraception Females Advise females of reproductive potential to use effective contraception during treatment and for at least 1 month after the final dose of warfarin sodium.”
🔗 Reference links
- FDA (approval record)ANDA040301
- DailyMed (FDA label)FDA Warfarin
- MedlinePlus (NIH)Warfarin
- WHO ATC/DDDB01AA03
- Darooyab (Iran)Warfarin
🇮🇷 Registered in Iran Darooyab · G-1932/Warfarin
Dosage forms with Iranian generic codes, per Darooyab.
- 12117 · WARFARIN SODIUM 0.5MG TAB · قرص وارفارین سدیم ۰٫۵ میلیگرم
- 08024 · WARFARIN SODIUM 1MG TAB · قرص وارفارین سدیم ۱ میلیگرم
- 02199 · WARFARIN SODIUM 2.5MG TAB · قرص وارفارین سدیم ۲٫۵ میلیگرم
- 12575 · WARFARIN SODIUM 2MG TAB · قرص وارفارین سدیم ۲ میلیگرم
- 10097 · WARFARIN SODIUM 3MG TAB · قرص وارفارین سدیم ۳ میلیگرم
- 12569 · WARFARIN SODIUM 4MG TAB · قرص وارفارین سدیم ۴ میلیگرم
- 01309 · WARFARIN SODIUM 5MG TAB · قرص وارفارین سدیم ۵ میلیگرم
- 12570 · WARFARIN SODIUM 6MG TAB · قرص وارفارین سدیم ۶ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Warfarin · 3FDA Warfarin · 2.3FDA Warfarin · 2FDA Warfarin · 8.4FDA Warfarin · 4FDA Warfarin · 8.2FDA Warfarin · 8.5FDA Warfarin · 8.3FDA Warfarin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1932/Warfarin
- Clinical review⚠ Unverified